echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Food News > Food Articles > Syngenta and Atticus settle azoxystrobin lawsuit

    Syngenta and Atticus settle azoxystrobin lawsuit

    • Last Update: 2022-08-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
     
    Syngenta sued agrochemical manufacturer Atticus LLC ("Atticus") in 2019 for infringing its patent right.
     
    In its complaint filed in the .
    .
    District Court for the Eastern District of North Carolina, Syngenta alleges that Atticus' Acadia 2 SC, Acadia ESQ, Aquila XL, Artavia 2 SC and Artavia Xcel products infringe certain Syngenta products involving azoxystrobi.
    Manufacturing paten.
    Azoxystrobin
     
    Details of the settlement agreement are being kept under wrap.
    Both parties agree that valid intellectual property rights are important to the industry and should be respecte.
    Atticus will continue to sell its azoxystrobin product.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.